Please login to the form below

Not currently logged in
Email:
Password:

Making digital health personal

digital health stock resized

What makes a tool successfully support adherence and deliver value-based care?

Deal Watch: February 2017

Medius Deal WatchActelion, Johnson & Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up

Holding on to hope for Alzheimer’s advances

Despite another late-stage failure, now is not the time to give up on the disease

Stress testing for the perfect compliance storm

...as governments and regulators impose new legislation and strengthen their compliance regimes

Lighting the way

How the UK’s Accelerated Access Review aims to guide medical innovations to their destination

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

Webinars

Assessing early market opportunity

To successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process.

PC: Are you Patient Centric or just Politically Correct?

Everyone in pharma is talking about patient centricity, but how is the drive received ‘on the ground’ among patients who are its focus? How is it unfolding and how far

Communicating innovation to payers and policy makers

Involving public affairs early during the development and commercialisation process of a new asset is critical to success when demonstrating value to payers and policy makers.

Scale & Strategy: Essential tools for transforming the commercial model

Most life sciences companies know they need to move their multichannel marketing forward, but that requires managing a greater volume of tactics that need to be developed, approved, implemented, and

Country reports

The death of the cancer drugs fund?

UK flagNHS England's siloed budget and its uncertain future

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Video

Webinar: Customer engagement design

Customer engagement design pharma Webinar: Customer engagement design

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

The impact of new technology on healthcare

Mindy Daeschner PSHealth PMLiVE speaks to Mindy Daeschner, director of healthcare technology company PSHealth.

White papers

Precision medicine and the changing role of the healthcare professional

The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of

How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma

eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation

Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet.

Pharma China Annual Forum 2017

We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nitro Digital

Nitro Digital is an award-winning full service digital marketing agency focused on the life science sector. We offer a strategic...

Infographics